Review: NAATs diagnose C difficile; vancomycin improves cure, and fidaxomicin reduces recurrence

Ann Intern Med. 2016 Jul 19;165(2):JC4. doi: 10.7326/ACPJC-2016-165-2-004.
No abstract available

MeSH terms

  • Aminoglycosides / therapeutic use*
  • Anti-Bacterial Agents / therapeutic use*
  • Clostridioides difficile*
  • Clostridium Infections / diagnosis*
  • Clostridium Infections / drug therapy*
  • Clostridium Infections / prevention & control
  • Fidaxomicin
  • Humans
  • Nucleic Acid Amplification Techniques*
  • Secondary Prevention
  • Vancomycin / therapeutic use*

Substances

  • Aminoglycosides
  • Anti-Bacterial Agents
  • Vancomycin
  • Fidaxomicin